Azole-resistant aspergillus fumigatus in the environment of Northern Italy, May 2011 to June 2012

Eurosurveillance

Volumn 19, Issue 12, 2014, Pages

  Prigitano, A ^a   Venier, V ^a   Cogliati, M ^a   De Lorenzis, G ^a   Esposto, M C ^a   Tortorano, A M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; CHLORAMPHENICOL; GENOMIC DNA; ITRACONAZOLE; PYRROLE; VORICONAZOLE; ANTIFUNGAL AGENT; POSACONAZOLE; TRIAZOLE DERIVATIVE;

ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLOSIS; CONTROLLED STUDY; ENVIRONMENTAL HEALTH; FUNGUS GROWTH; GENE MUTATION; GENETIC SUSCEPTIBILITY; GENOTYPE; ITALY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATIENT CARE; POINT MUTATION; POLYMERASE CHAIN REACTION; PREVALENCE; PROMOTER REGION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; ASPERGILLUS FUMIGATUS; DRUG EFFECT; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MUTATION; SENTINEL SURVEILLANCE;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; HUMANS; ITALY; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; MUTATION; POLYMERASE CHAIN REACTION; SENTINEL SURVEILLANCE; SOIL MICROBIOLOGY; TRIAZOLES;

EID: 84897089285     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.12.20747     Document Type: Article

References (27)

1. European Centre for Disease Prevention and Control (ECDC). Technical Report. Risk assessment on the impact of environmental usage of triazoles on the development and spread of resistance to medical triazoles in Aspergillus species. Stockholm: ECDC;2013.
2. Prentice AG, Glasmacher A, Hobson RP, Schey S, Barnes RA, Donnelly JP, et al. Guidelines on the management of invasive fungal infection during therapy for haematological malignancy. London: British Committee for Standards in Haematology; 2010.
3. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46(3):327-60. http://dx.doi.org/10.1086/525258
4. Grossi PA, Gasperina DD, Barchiesi F, Biancofiore G, Carafiello G, De Gasperi A, et al. Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients. Transplant Proc. 2011;43(6):2463-71. http://dx.doi.org/10.1016/j.transproceed.2011.06.020
5. Herbrecht R, Flückiger U, Gachot B, Ribaud P, Thiebaut A, Cordonnier C. Antifungal Therapy in Leukemia Patients. UPDATE ECIL 4: Fourth European Conference on Infections in Leukaemia (ECIL-4); 2011 Sep 8-10; Juan-Les-Pins, France.
6. Verweij PE, Snelders E, Kema GH Mellado E, Melchers WJ. Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? Lancet Infect Dis. 2009;9(12):789-95. http://dx.doi.org/10.1016/S1473-3099(09)70265-8
7. Howard SJ, Cerar D, Anderson MJ, Albarrag A, Fisher MC, Pasqualotto AC, et al. Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis. 2009;15(7):1068-76. http://dx.doi.org/10.3201/eid1507.090043
8. Mortensen KL, Mellado E, Lass-Flörl C, Rodriguez-Tudela JL, Johansen H K, Arendrup MC. Environmental study of azole-resistant Aspergillus fumigatus and other Aspergilli in Austria, Denmark, and Spain. Antimicrob Agents Chemother. 2010;54(11):4545-9. http://dx.doi.org/10.1128/AAC.00692-10
9. Mellado E, Garcia-Effron G, Alcazar-Fuoli L, Melchers WJ, Verweij PE, Cuenca-Estrella M, et al. A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations. Antimicrob Agents Chemother. 2007;51(6):1897-904. http://dx.doi.org/10.1128/AAC.01092-06
10. Mellado E, Diaz-Guerra TM, Cuenca-Estrella M, Rodriguez-Tudela JL. Identification of two different 14-α sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigates and other Aspergillus species. J Clin Microbiol. 2001;39(7):2431-8. http://dx.doi.org/10.1128/JCM.39.7.2431-2438.2001
11. Diaz-Guerra TM, Mellado E, Cuenca-Estrella M, Rodriguez-Tudela JL. A point mutation in the 14-α sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother. 2003;47(3):1120-24. http://dx.doi.org/10.1128/AAC.47.3.1120-1124.2003
12. Snelders E, Huis In't Veld RA, Rijs AJ, Kema GH, Melchers WJ, Verweij PE. Possible environmental origin of resistance of Aspergillus fumigatus to medical triazoles. Appl Environ Microbiol. 2009;75(12):4053-7. http://dx.doi.org/10.1128/AEM.00231-09
13. Van Der Linden JW, Arendrup MC, Verweij PE. Prospective international surveillance of azole resistance in Aspergillus fumigatus (Af) (SCARE-network). Abstract M 490 presented at: 51th ICAAC Interscience Conference on Antimicrobial Agents and Chemotherapy; 2011 Sep 17-20; Chicago, IL.
14. Rodriguez-Tudela JL, Arendrup MC, Arikan S, Barchiesi F, Bille J, Chryssanthou E, et al. EUCAST DEFINITIVE DOCUMENT E. DEF 9.1: Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds. EUCAST E. DEF 9.1. 2008;1-13.
15. Arendrup MC, Cuenca-Estrella M, Lass-Flörl C, Hope WW; European Committee on Antimicrobial Susceptibility Testing Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST). EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole. Clin Microbiol Infect. 2012;18(7):E248-50. http://dx.doi.org/10.1111/j.1469-0691.2012.03890.x
16. Verweij PE, Howard SJ, Melchers WJ, Denning DW. Azole-resistance in Aspergillus: proposed nomenclature and breakpoints. Drug Resist Updat. 2009;12(6):141-7. http://dx.doi.org/10.1016/j.drup.2009.09.002
17. Hope WW, Cuenca-Estrella M, Lass-Flörl C, Arendrup MC; European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST). EUCAST Technical Note on Voriconazole and Aspergillus spp. Clin Microbiol Infect. 2013;19(6):E278-80. http://dx.doi.org/10.1111/1469-0691.12148
18. de Valk HA, Meis JF, Curfs IM, Muehlethaler K, Mouton JW, Klaassen CH. Use of a novel panel of nine short tandem repeats for exact and high-resolution fingerprinting of Aspergillus fumigatus isolates. J Clin Microbiol. 2005;43(8):4112-20. http://dx.doi.org/10.1128/JCM.43.8.4112-4120.2005
19. Anderson JB. Evolution of antifungal-drug resistance: mechanisms and pathogen fitness. Nat Rev Microbiol. 2005;3(7):547-56. http://dx.doi.org/10.1038/nrmicro1179
20. Hof H. Critical annotations to the use of azole antifungals for plant protection. Antimicrob Agents Chemother. 2001;45 (11):2987-90. http://dx.doi.org/10.1128/AAC.45.11.2987-2990.2001
21. Snelders E, Van der Lee HA, Kuijpers J, Rijs AJ, Varga J, Samson RA, et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med. 2008;5(11):e219. http://dx.doi.org/10.1371/journal.pmed.0050219
22. Howard SJ, Pasqualotto AC, Denning DW. Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis. Clin Microbiol Infect 2010;16(6):683-8. http://dx.doi.org/10.1111/j.1469-0691.2009.02911.x
23. Jeurissen A, Cooreman S, Van Kerckhoven W, Van Leemput J, Vanhove P, Lagrou K, et al. Invasive pulmonary aspergillosis due to a multi-azole resistant Aspergillus fumigatus. Acta Clinica Belgica 2012;67(1):46-8 http://dx.doi.org/10.1179/ACB.67.1.2062627
24. Hamprecht A, Buchheidt D, Vehreschild JJ, Cornely OA, Spiess B, Plum G, et al. Azole-resistant invasive aspergillosis in a patient with acute myeloid leukaemia in Germany. Euro Surveillance 2012;17(36):20262.
25. Rath PM, Buchheidt D, Spiess B, Arfanis E, Buer J, Steinmann J. First reported case of azole-resistant Aspergillus fumigates due to the TR/L98H mutation in Germany. Antimicrob Agents Chemother 2012;56(11):6060-61. http://dx.doi.org/10.1128/AAC.01017-12
26. Rodriguez-Tudela JL, Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Monzon A, Cuenca-Estrella M. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus. Antimicrob Agents Chemother 2008, 52(7): 2468-72. http://dx.doi.org/10.1128/AAC.00156-08
27. Snelders E, Karawajczyk A, Schaftenaar G, Verweij PE, Melchers WJ. Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling. Antimicrob Agents Chemother. 2010, 54(6):2425-30. http://dx.doi.org/10.1128/AAC.01599-09